# Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.

Study · id `cardio:ct-nct03304496` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03304496](<https://clinicaltrials.gov/study/NCT03304496>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03304496

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 1400 participants.

## Technical summary

Registry record NCT03304496. Randomized; triple masking; primary purpose supportive care. Start 2018-03-30 (actual); primary completion 2019-03-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose supportive care
- Phase: Phase 4
- Enrolled: 1400 participants (planned count; ClinicalTrials.gov record NCT03304496, source copy `cardio:ctgov-nct03304496-2026-03-18`, retrieved 2026-10-26)
- Started: 2018-03-30 (actual) (ClinicalTrials.gov record NCT03304496, source copy `cardio:ctgov-nct03304496-2026-03-18`, retrieved 2026-10-26)
- Primary completion: 2019-03-30 (actual) (ClinicalTrials.gov record NCT03304496, source copy `cardio:ctgov-nct03304496-2026-03-18`, retrieved 2026-10-26)
- Completion: 2026-03-31 (anticipated) (ClinicalTrials.gov record NCT03304496, source copy `cardio:ctgov-nct03304496-2026-03-18`, retrieved 2026-10-26)
- Countries: Mexico (ClinicalTrials.gov record NCT03304496, source copy `cardio:ctgov-nct03304496-2026-03-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03304496-2026-03-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.
- Acronym: NITRAD-Sub
- Condition: Coronary Artery Disease
- Intervention (Drug): Nitroglycerin 100 MCG/ML Injectable Solution
- Intervention (Drug): Saline Solution
- Lead sponsor: Instituto Nacional de Cardiologia Ignacio Chavez
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Instituto Nacional de Cardiologia Ignacio Chavez (`cardio:org-instituto-nacional-de-cardiologia-ignacio-chavez`)

## Provenance

Content hash: 59e490dddbd5ef016bc3b03be010c84266eff9ef76381fc4297dc07e1bd50b93
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
